Valuation : Vivos Inc.

Market Cap 24.5M 21.11M 19.98M 18.11M 33.98M 2.34B 34.15M 237M 91.27M 1.19B 92M 89.98M 3.76B P/E 2024
-16.2x
P/E 2025 -10.2x
Enterprise Value 23.05M 19.86M 18.81M 17.05M 31.98M 2.2B 32.14M 223M 85.89M 1.12B 86.57M 84.67M 3.54B EV / Sales 2024
1,724x
EV / Sales 2025 438x
Free-Float
95.76%
Yield 2024 *
-
Yield 2025 -
1 day-3.75%
1 week+17.06%
Current month+15.23%
1 month+7.86%
3 months-9.23%
6 months-30.51%
Current year-14.37%
1 week 0.04
Extreme 0.045
0.06
1 month 0.04
Extreme 0.045
0.06
Current year 0.04
Extreme 0.045
0.12
1 year 0.04
Extreme 0.045
0.12
3 years 0.04
Extreme 0.04119
0.26
5 years 0.04
Extreme 0.04
0.26
10 years 0.01
Extreme 0.0065
8
Manager TitleAgeSince
Chief Executive Officer 79 2016-12-13
President 44 2025-09-14
Director of Finance/CFO 59 2018-11-30
Director TitleAgeSince
Chairman 81 2016-12-13
Director/Board Member 79 2017-08-01
Date Insider Type Main position Quantity % Market Cap. Importance
8/10/26 Buy

Chief Executive Officer

150,000 0.0304%
8/10/26 Buy

Chairperson

50,000 0.0101%
7/22/26 Buy

Chairperson

32,000 0.0065%
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%+17.06%-36.56%-4.92% 24.5M
+0.73%-5.04%-31.76%-2.35% 12.56B
-2.07%-2.38%+11.19%+9.93% 4.13B
-3.46%-4.65%-46.75%-58.46% 1.21B
-2.76%-5.97%-44.19%-45.09% 1.07B
+0.43%-1.47%+15.36%+88.23% 1.05B
-1.47%-7.83% - - 954M
-2.35%-6.69%-41.36% - 953M
-4.21%-3.00%+27.85%+92.66% 489M
+1.23%+10.18%+60.19% - 330M
Average -1.77%-3.57%-9.56%+11.43% 2.28B
Weighted average by Cap. -0.50%-4.52%-20.49%+1.49%

Financials

2024 2025
Net sales 28K 24.12K 22.84K 20.7K 38.84K 2.67M 39.03K 271K 104K 1.36M 105K 103K 4.3M 68.38K 58.92K 55.78K 50.56K 94.86K 6.53M 95.34K 663K 255K 3.32M 257K 251K 10.5M
Net income -2.91M -2.51M -2.37M -2.15M -4.04M -278M -4.06M -28.2M -10.84M -141M -10.93M -10.69M -447M -3.07M -2.64M -2.5M -2.27M -4.25M -293M -4.27M -29.71M -11.42M -149M -11.51M -11.26M -471M
Net Debt -2.21M -1.91M -1.81M -1.64M -3.07M -211M -3.08M -21.44M -8.24M -108M -8.31M -8.13M -340M -1.44M -1.24M -1.18M -1.07M -2M -138M -2.01M -13.99M -5.38M -70.2M -5.42M -5.31M -222M
Logo Vivos Inc.
Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.
Employees
1
Date Price Change Volume
26-09-11 US$0.0496 -0.02% 950,695
26-09-10 US$0.0496 +2.59% 1,126,535
26-09-09 US$0.0484 -2.56% 957,432
26-09-08 US$0.0496 -1.55% 424,124
26-09-04 US$0.0504 +0.48% 1,846,204
  1. Stock Market
  2. Stocks
  3. RDGL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!